TechnoDerma Medicines announced the completion of Series A Financing

News

}

Home / News / Portfolio Highlights / Portfolio Highlights detail

Time: 2021-04-14

Source: Viva Biotech

[Abstract]:This round of financing will be mainly used to advance the clinical trials and follow-up R&D.

Shanghai, China——Recently, Jiaxing TechnoDerma Medicines Inc., a biotech start-up invested and incubated by Viva BioInnovator, which focused on the R&D of innovative drugs for skin indications, announced the completion of tens of millions of yuan in Series A financing. The financing funds will be used to advance the clinical trials and follow-up R&D, and strengthen the development of the R&D team.

Previous Page：VivaVision Completed 300 Million RMB Series D Financing Next Page：Phenomic AI：the biotech business harnessing the power of AI

Back

Media contact: vivapr@vivabiotech.com

This site uses cookies and your privacy choices are important to us

We use cookies to improve the user experience and to analyze website traffic. By clicking "Accept", you consent to the use of cookies on our website, such as cookies policies.